Antitumor agent-82
Antitumor agent-82 (compound 6g) is a potent anti-tumor agent. Antitumor agent-82 shows anti-proliferative activity. Antitumor agent-82 induces cell Autophagy by the ATG5/ATG7 signaling pathway.
For research use only. We do not sell to patients.
- CAS No.: 3037605-45-8
- Formula: C32H42N6
- Molecular Weight:510.72
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 786-0 | IC50 |
2.71 μM
Compound: 6g
|
Antiproliferative activity against human 786-0 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human 786-0 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 36459757] |
| A-375 | IC50 |
11.5 μM
Compound: 6g
|
Antiproliferative activity against human A-375 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human A-375 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 36459757] |
| BGC-823 | IC50 |
24.8 μM
Compound: 6g
|
Antiproliferative activity against human BGC-823 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human BGC-823 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 36459757] |
| CWR22R | IC50 |
3.86 μM
Compound: 6g
|
Antiproliferative activity against human 22Rv1 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human 22Rv1 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 36459757] |
| ECa-109 cell line | IC50 |
8.62 μM
Compound: 6g
|
Antiproliferative activity against human Eca-109 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human Eca-109 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 36459757] |
| HCT-116 | IC50 |
4.57 μM
Compound: 6g
|
Antiproliferative activity against human HCT-116 cells expressing ATG5-FLAG assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
Antiproliferative activity against human HCT-116 cells expressing ATG5-FLAG assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
|
[PMID: 36459757] |
| HCT-116 | IC50 |
4.71 μM
Compound: 6g
|
Antiproliferative activity against p53 knockout human HCT-116 cells assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
Antiproliferative activity against p53 knockout human HCT-116 cells assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
|
[PMID: 36459757] |
| HCT-116 | IC50 |
4.97 μM
Compound: 6g
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
|
[PMID: 36459757] |
| HCT-116 | IC50 |
5.09 μM
Compound: 6g
|
Antiproliferative activity against human HCT-116 cells expressing ATG7-FLAG assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
Antiproliferative activity against human HCT-116 cells expressing ATG7-FLAG assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
|
[PMID: 36459757] |
| HCT-116 | IC50 |
7.36 μM
Compound: 6g
|
Antiproliferative activity against ATG5 knockout human HCT-116 cells assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
Antiproliferative activity against ATG5 knockout human HCT-116 cells assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
|
[PMID: 36459757] |
| HCT-116 | IC50 |
7.89 μM
Compound: 6g
|
Antiproliferative activity against ATG7 knockout human HCT-116 cells assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
Antiproliferative activity against ATG7 knockout human HCT-116 cells assessed as inhibition of cell growth measured after 24 hrs by CCK-8 assay
|
[PMID: 36459757] |
| HT-29 | IC50 |
2.02 μM
Compound: 6g
|
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human HT-29 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 36459757] |
| KB | IC50 |
8.12 μM
Compound: 6g
|
Antiproliferative activity against human KB cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human KB cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 36459757] |
| MCF7 | IC50 |
13.5 μM
Compound: 6g
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 36459757] |
| SK-OV-3 | IC50 |
10.6 μM
Compound: 6g
|
Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
Antiproliferative activity against human SK-OV-3 cells assessed as inhibition of cell growth measured after 48 hrs by MTT assay
|
[PMID: 36459757] |
In Vitro
Antitumor agent-82 (compound 6g) (0-100 μM; 48 h) shows anti-proliferative activity with IC50s of 24.8, 13.5, 11.5, 2.71, 2.02, 4.53 μM for BGC-823, MCF7, A375, 786-O, HT-29, Blu-87 cells, respectively[1].
Antitumor agent-82 (0-4 μM; 0-7 days) inhibits cell growth in a dose and time-dependent manner against HCT116 cells[1].
Antitumor agent-82 (0-5 μM; 0-60 h) activates autophagy by the ATG5/ATG7 signaling pathway in HCT116 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:BGC-823, MCF7, A375, 786-O, HT-29, Blu-87 cells
-
Concentration:0-100 µM
-
Incubation Time:48 h
-
Result:Showed antiproliferative activity with IC50s of 24.8, 13.5, 11.5, 2.71, 2.02, 4.53 µM for BGC-823, MCF7, A375, 786-O, HT-29, Blu-87 cells, respectively.
-
Cell Line:HCT116 cells
-
Concentration:0-5 µM
-
Incubation Time:0-60 h
-
Result:Induced autophagy with no influences on the expression of caspase-3, cleaved caspase-3 and p53 protein, significantly increased the expression of LC3-II and p62.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:6-week-old male BALB/c mice[1]
-
Dosage:45 mg/kg
-
Administration:I.p.; every two days for 16 days
-
Result:Reduced tumor volume and resulted in a considerable reduction of the tumor weight of 69.69%.
Chemical Information
-
CAS No. 3037605-45-8
-
Molecular Weight 510.72
-
Formula C32H42N6
-
SMILES
CN1CCN(CC1)CC2=NC(CN3CCN(CC3)C)=C4C(C5=C(N4CCCC6=CC=CC=C6)C=CC=C5)=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)